Loading stock data…
Cuprina Holdings (Cayman) Limit (CUPR)
$3.12-0.04 (-1.27%)
Market ClosedLast close Sep 8
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cuprina Holdings (Cayman) Limited in the Healthcare sector is trading at $3.12 with a market capitalization of $8M. The stock is currently near its 52-week low of $1.76, remaining 9.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.31M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
552,694
Recent News
Sector Update: Healthcare Stocks Softer Late Afternoon
Healthcare stocks declined late Monday afternoon with the NYSE Healthcare Index decreasing 0.6% and
Top Midday Gainers
Cuprina (CUPR) said Monday its subsidiary Cuprina Pte Ltd. obtained 510(k) clearance from the US Foo
Sector Update: Healthcare Stocks Softer Monday Afternoon
Healthcare stocks declined Monday afternoon with the NYSE Healthcare Index dropping 0.7% and the Sta
Why Did CUPR Stock Surge Over 150% Today?
Cuprina Holdings said its medicinal larvae product, MEDIFLY Maggots, has been approved by the FDA to treat non-healing injuries, such as diabetic foot ulcers.